Highly Active Antiretroviral Therapy and Cardiovascular Complications in HIV-Infected Patients

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|9|18|1475-1481

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.9, Iss.18, 2003-07, pp. : 1475-1481

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

High Variability of Indinavir and Nelfinavir Pharmacokinetics in HIV-Infected Patients with a Sustained Virological Response on Highly Active Antiretroviral Therapy

By Goujard Cécile  

Clinical Pharmacokinetics, Vol. 44, Iss. 12, 2005-01 ,pp. : 1267-1278

Adis International

Access to resources Recommend Favorite

Cardiovascular risk associated with antiretroviral therapy in HIV-infected patients

By Calza Dr Leonardo   Manfredi Roberto   Chiodo Francesco  

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 11, 2006-11 ,pp. : 1497-1516

Informa Healthcare

Access to resources Recommend Favorite

Metabolic complications of antiretroviral therapy in HIV-infected children

By Eley Brian  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 1, 2008-01 ,pp. : 37-49

Informa Healthcare

Access to resources Recommend Favorite

Nephrotoxicity associated with antiretroviral therapy in HIV-infected patients

By Harris Marianne  

Expert Opinion on Drug Safety, Vol. 7, Iss. 4, 2008-07 ,pp. : 389-400

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Drug Monitoring: A Tool to Individualize Highly Active Antiretroviral Therapy in HIV Infected Patients

By  

Current Pharmaceutical Analysis, Vol. 2, Iss. 3, 2006-08 ,pp. : 205-217

Bentham Science Publishers

Access to resources Recommend Favorite